Many patients with diabetic nephropathy progress to end-stage renal disease. New research in disease detection, diagnosis, and novel treatments will hopefully alleviate the burden of diabetic nephropathy in the future.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy
Scientific Reports Open Access 11 August 2021
-
A case control association study of COMT gene polymorphism (I/D) with type 2 diabetes and its related factors in Pakistani Punjabi population
Journal of Diabetes & Metabolic Disorders Open Access 06 May 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Papale, M. et al. Urine proteome analysis may allow non-invasive differential diagnosis of diabetic nephropathy. Diabetes Care 33, 2409–2415 (2010).
Overgaard, A. J. et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Science 8, 4 (2010).
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S. & Thornalley, P. J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52, 2110–2120 (2003).
Alkhalaf, A. et al. A double-blind, randomized, placebo controlled clinical trial on benfotiamine treatment in patietns with diabetic nephropathy. Diabetes Care 33, 1598–1601 (2010).
Rabbani, N. et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52, 208–212 (2009).
Ismail-Beigi, F. et al. Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419–430 (2010).
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).
Zoungas, A. et al. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. Diabetologia 53 (Suppl. 1), S98 (2010).
Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129–139 (2009).
Tessari, P. et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59, 2152–2159 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Gray, S., Cooper, M. Alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 7, 71–73 (2011). https://doi.org/10.1038/nrneph.2010.176
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2010.176
This article is cited by
-
Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy
Scientific Reports (2021)
-
Noninvasive evaluation of early diabetic nephropathy using diffusion kurtosis imaging: an experimental study
European Radiology (2021)
-
A case control association study of COMT gene polymorphism (I/D) with type 2 diabetes and its related factors in Pakistani Punjabi population
Journal of Diabetes & Metabolic Disorders (2015)
-
Emerging Roles for miRNAs in the Development, Diagnosis, and Treatment of Diabetic Nephropathy
Current Diabetes Reports (2013)
-
Towards microRNA-based therapeutics for diabetic nephropathy
Diabetologia (2013)